Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ·Healthcare·Biotechnology
$3.43
-1.58%
Mkt Cap $1.57B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (7 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+221.2%
Consensus $11.00 vs current $3.43
NASDAQ·Healthcare·Biotechnology
$3.43
-1.58%
Mkt Cap $1.57B
Buy
2
Hold
1
Sell
0
Price Target (7 analysts)
$11.00
Range $11.00 – $11.00
+221.2%
Consensus $11.00 vs current $3.43